Daniel Plourde - Gabelli Healthcare Vice President
| GRX Stock | USD 10.42 0.12 1.17% |
Insider
Daniel Plourde is Vice President of Gabelli Healthcare WellnessRx since 2021.
| Age | 39 |
| Tenure | 3 years |
| Address | One Corporate Center, Rye, NY, United States, 10580-1422 |
| Phone | 914 921 5000 |
| Web | https://www.gabelli.com/Template/fundinfo.cfm?tid= |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Frances Rathke | John Hancock Income | 60 | |
| John Caroselli | MFS Investment Grade | 66 | |
| John Birch | Gabelli MultiMedia Mutual | 69 | |
| Daniel Harding | Gabelli Convertible And | 67 | |
| Keith Quinton | Eaton Vance National | 63 | |
| Deidre Walsh | Eaton Vance National | 50 | |
| Marcus Smith | Eaton Vance National | 55 | |
| John Birch | Gabelli Convertible And | 69 | |
| Peter Jones | MFS Investment Grade | 65 | |
| Caesar LLB | GAMCO Natural Resources | N/A | |
| Vincent Enright | Gabelli Convertible And | 76 | |
| Richard Froio | Eaton Vance National | 53 | |
| Laurissa Martire | Gabelli Global Small | 43 | |
| Calgary Avansino | Gabelli Global Small | 44 | |
| Stephen Meter | Federated Premier Municipal | 45 | |
| CPA CPA | GAMCO Natural Resources | 72 | |
| Christopher Marangi | GAMCO Natural Resources | 50 | |
| John Fisher | Federated Premier Municipal | 64 | |
| James Kilman | MFS Investment Grade | 59 | |
| John Ball | Gabelli Convertible And | 44 | |
| Leslie Foley | Gabelli Convertible And | 52 | |
Management Performance
| Return On Equity | -13.74 |
Gabelli Healthcare Leadership Team
Elected by the shareholders, the Gabelli Healthcare's board of directors comprises two types of representatives: Gabelli Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gabelli. The board's role is to monitor Gabelli Healthcare's management team and ensure that shareholders' interests are well served. Gabelli Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gabelli Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruce Alpert, President | ||
| CFA CFA, Portfolio Mang | ||
| Mario CFA, Portfolio Mang | ||
| Kuni Nakamura, Independent Trustee | ||
| David Schachter, Vice President | ||
| Bruce CPA, Ex Officer | ||
| Agnes Mullady, Principal Executive Officer and President Principal Financial Officer, Principal Accounting Officer and Treasurer | ||
| Daniel Plourde, Vice President | ||
| Calgary Avansino, Independent Trustee | ||
| Kevin Dreyer, Portfolio Mang | ||
| Adam Tokar, Vice President | ||
| Andrea Mango, Vice President, Secretary | ||
| Wayne CFA, Assistant Ombudsman | ||
| CPA CPA, Ex Officer | ||
| Salvatore Zizza, Independent Trustee | ||
| Mario Gabelli, Chairman of the Board of Trustees, Chief Investment Officer | ||
| Leslie Foley, Independent Trustee | ||
| Bethany Uhlein, Assistant Vice President and Ombudsman | ||
| Vincent Enright, Independent Director | ||
| Peter Goldstein, Vice President Secretary | ||
| Richard Walz, Chief Compliance Officer | ||
| Carter Austin, Vice President | ||
| James Conn, Lead Independent Trustee | ||
| Jeffrey Jonas, Trustee | ||
| Jonas CFA, Portfolio Mang | ||
| Anthonie Ekris, Independent Trustee | ||
| John Ball, Treasurer and Principal Financial and Accounting Officer | ||
| Robert Kolodny, Independent Trustee |
Gabelli Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Gabelli Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.74 | ||||
| Shares Outstanding | 15.6 M | ||||
| Shares Owned By Insiders | 1.54 % | ||||
| Shares Owned By Institutions | 25.05 % | ||||
| Number Of Shares Shorted | 8.44 K | ||||
| Price To Earning | 4.15 X | ||||
| Price To Book | 0.93 X | ||||
| Price To Sales | 127.51 X | ||||
| Revenue | 1.24 M | ||||
| EBITDA | 3.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gabelli Stock Analysis
When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.